This site contains promotional information intended only for healthcare professionals resident in Great Britain.
Information on how to access XELJANZ®▼ (tofacitinib citrate) prescribing information and adverse event reporting can be found at the bottom of the page.
Lab monitoring recommendations for patients taking XELJANZ
|After 4 to 8 weeks||At 8 weeks||Every 3 months thereafter|
|Lipids||After 8 weeks following initiation of therapy|
|Liver enzymes||Routine monitoring of liver test and prompt investigation of the cause of liver enzyme elevation are also recommended|
|Avoid initiating treatment in patients with:||Absolute lymphocyte count <0.75 x109 cells/L||Absolute neutrophil count <1.2 x109 cells/L||Haemoglobin levels
|Severe hepatic impairment|
Please refer to the full PI for recommended dose modifications based on changes in lab tests.
Explore the resources avaliable for patients who have been prescribed XELJANZ for PsA
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2021 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?